David W. J. McGirr, Director at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 130,862 shares at $65.64 ($8.5M) on 2025-06-03, disclosed to the SEC on 2025-06-05.
Scheduled sale ($8.5M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $65.15 | 55,558 | $3.6M | 42.4% |
| 2 | $65.15 | 55,558 | $3.6M | 42.4% |
| 3 | $65.64 | 9,873 | $648K | 7.6% |
| 4 | $65.64 | 9,873 | $648K | 7.6% |
| Total | $65.22 avg | 130,862 | $8.5M | 100% |
| Filing → |
| RLYP | SELL | 2015-06-15 | $42K | — | Filing → |
| ROKA | BUY | 2014-11-17 | $180K | — | Filing → |
| CBST | SELL | 2012-09-24 | $747K | — | Filing → |